Views & Analysis | Perspectives on pharma industry issues

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Articles

A beginner’s guide to digital pharma: part 8 – emerging chan...

The internet isn’t all about Google, Facebook, Twitter and LinkedIn you know! This week we take a look at some of the emerging channels that are worth giving a go. Over the last few months we’ve covered off the leading social networking sites that can be used both at home and at work. However, new ideas are always…

Articles

A beginner’s guide to digital pharma: part 9 – mobile apps!

We’re on the move in the latest part of our beginner’s guide to digital pharma. Welcome to the world of mobile apps, which might just change the face of healthcare forever. When I got up this morning I found myself feeling a bit groggy, so decided to check my sleep cycle app on my iPhone to see when I slept most during the night…

Articles

A beginner’s guide to digital pharma: part 11 – SEO

Did you find this article through Google? If so, then SEO played a part and in our latest piece on all things digital we explain how to make your brand visible to the search engines. There is so much to say about the “art” of search engine optimisation, or SEO as it’s commonly called, that it’s hard to know where to begin…

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.